Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786370 · ClinicalTrials.gov registry record · Phase 4
Dexmedetomidine vs. Propofol for Cataract Surgery
A Phase 4 study, sponsored by The Cooper Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT00786370 is a Phase 4 study that has completed, run by The Cooper Health System. The registered enrollment target is 24 participants.
The verdict
NCT00786370, a Phase 4 study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The use of dexmedetomidine in cataract surgery is still limited and to date only one study has examined anesthetic technique in this patient population. This pilot study will therefore compare the use of dexmedetomidine and propofol in subjects undergoing cataract surgery. The primary endpoint will be based on simple cardiorespiratory measures often associated with complications from sedation as well as assessment of the achieved sedation by the attending anesthesiologist and surgeon.
Interventions
- DRUG Propofol
- DRUG dexmedetomidine
- DRUG Dexemedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00786370
The ClinicalTrials.gov registry entry for NCT00786370 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Propofol is the first listed.
NCT00786370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00786370 about?
NCT00786370 is a clinical study titled "Dexmedetomidine vs. Propofol for Cataract Surgery". The use of dexmedetomidine in cataract surgery is still limited and to date only one study has examined anesthetic technique in this patient population. This pilot study will therefore compare the use of dexmedetomidine and propofol in subjects undergoing cataract surgery. The primary endpoint will ...
What is the current status of trial NCT00786370?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2008-04. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00786370?
The interventions under investigation include: Propofol (DRUG), dexmedetomidine (DRUG), Dexemedetomidine (DRUG).
Who is sponsoring clinical trial NCT00786370?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.